Research summaries
Cost questions do not stand apart from safety questions.
Ibogaine is a psychoactive substance, and discussions of its use regularly involve medical and regulatory uncertainty. A basic reference point is the overview of ibogaine’s pharmacology and history, while the U.S. Drug Enforcement Administration lists ibogaine in Schedule I controlled-substances materials.
Our summaries are not medical advice and do not assess whether a program is appropriate for any individual. They are intended to help families notice when cost claims are detached from screening, monitoring, emergency planning, or follow-up. For questions involving head injury concerns, readers can compare the narrower discussion at ibogaine and concussions with the information a program actually provides.
Some readers arrive with a specific time-based claim in mind. The resource on how long ibogaine effects may last can help frame that question, but duration claims should not be treated as a substitute for individualized professional assessment.